CAR--话题@MedSci

#CAR-#

459篇内容 | 2254人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781168, encodeId=052b1e81168d0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=艾森RTCA助力CAR-T疗法研究, objectType=article, longId=106660, objectId=eb6c106660ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb6c106660ac, replyNumber=0, likeNumber=55, createdTime=2017-10-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb6c106660ac, moduleTitle=艾森RTCA助力CAR-T疗法研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb6c106660ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781175, encodeId=78771e8117548, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：首次发现肿瘤复发后CAR-T细胞自发“复活”，并再起作用！, objectType=article, longId=111357, objectId=0e7311135e13, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e7311135e13, replyNumber=0, likeNumber=54, createdTime=2017-10-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e7311135e13, moduleTitle=NEJM：首次发现肿瘤复发后CAR-T细胞自发“复活”，并再起作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e7311135e13)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781141, encodeId=4efb1e811413f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报, objectType=article, longId=88742, objectId=e66488e4287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66488e4287, replyNumber=0, likeNumber=79, createdTime=2017-12-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66488e4287, moduleTitle=嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66488e4287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781167, encodeId=97191e81167c9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床, objectType=article, longId=106659, objectId=2b8c10665963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b8c10665963, replyNumber=0, likeNumber=66, createdTime=2017-11-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b8c10665963, moduleTitle=博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b8c10665963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781153, encodeId=afc21e811533c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=「创意支架」搭载CAR-T，联合免疫疗法助力消灭实体瘤！, objectType=article, longId=97163, objectId=6f129e163b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f129e163b0, replyNumber=0, likeNumber=63, createdTime=2018-01-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f129e163b0, moduleTitle=「创意支架」搭载CAR-T，联合免疫疗法助力消灭实体瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f129e163b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781139, encodeId=0fc51e81139bc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=挑战实体瘤，CAR-T新锐的秘诀是？, objectType=article, longId=87617, objectId=6d488e617a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d488e617a8, replyNumber=0, likeNumber=75, createdTime=2017-02-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d488e617a8, moduleTitle=挑战实体瘤，CAR-T新锐的秘诀是？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d488e617a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781125, encodeId=28471e811259d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤, objectType=article, longId=79404, objectId=3433e9404ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3433e9404ae, replyNumber=0, likeNumber=87, createdTime=2017-05-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3433e9404ae, moduleTitle=Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3433e9404ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781137, encodeId=03221e811373b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=综述：CAR-T疗法、TCR-T疗法研发格局, objectType=article, longId=87275, objectId=13948e275d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13948e275d4, replyNumber=0, likeNumber=88, createdTime=2017-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13948e275d4, moduleTitle=综述：CAR-T疗法、TCR-T疗法研发格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13948e275d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781152, encodeId=1efe1e811521c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=附属仁济医院李宗海团队CAR-T细胞治疗生物大楼落成启用, objectType=article, longId=97100, objectId=febb9e1009d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=febb9e1009d, replyNumber=0, likeNumber=49, createdTime=2018-04-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=febb9e1009d, moduleTitle=附属仁济医院李宗海团队CAR-T细胞治疗生物大楼落成启用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=febb9e1009d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781154, encodeId=f79c1e8115451, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=人源CAR-T疗法挽救三位急淋白血病患者生命, objectType=article, longId=97347, objectId=3f119e34745, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f119e34745, replyNumber=0, likeNumber=58, createdTime=2018-03-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f119e34745, moduleTitle=人源CAR-T疗法挽救三位急淋白血病患者生命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f119e34745)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781145, encodeId=b71a1e81145f5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=浙医一院CAR-T治疗恶性血液病进展振奋中美法专家, objectType=article, longId=90322, objectId=f3ef90322f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ef90322f6, replyNumber=0, likeNumber=83, createdTime=2017-05-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ef90322f6, moduleTitle=浙医一院CAR-T治疗恶性血液病进展振奋中美法专家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ef90322f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781147, encodeId=392a1e8114732, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=美国FDA批准施维雅/辉瑞通用型CAR-T疗法进入临床试验, objectType=article, longId=92101, objectId=8c7e921016c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c7e921016c, replyNumber=0, likeNumber=60, createdTime=2017-09-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c7e921016c, moduleTitle=美国FDA批准施维雅/辉瑞通用型CAR-T疗法进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c7e921016c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781140, encodeId=f4321e8114017, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, objectType=article, longId=88127, objectId=d4478812e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4478812e0b, replyNumber=0, likeNumber=87, createdTime=2017-03-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4478812e0b, moduleTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4478812e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781112, encodeId=f21b1e811128b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=艾辉胜教授：微移植和CAR-T联合治疗研究, objectType=article, longId=71318, objectId=bdcfe131825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdcfe131825, replyNumber=0, likeNumber=60, createdTime=2016-10-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdcfe131825, moduleTitle=艾辉胜教授：微移植和CAR-T联合治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdcfe131825)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781113, encodeId=6e541e81113f6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Immunity：重大进展！利用新型CAR-T免疫疗法治疗实体瘤, objectType=article, longId=71538, objectId=912ae15380f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=912ae15380f, replyNumber=0, likeNumber=79, createdTime=2016-10-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=912ae15380f, moduleTitle=Immunity：重大进展！利用新型CAR-T免疫疗法治疗实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=912ae15380f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781136, encodeId=44351e81136b7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=重磅：CAR-T首次消灭实体瘤，意义非凡！, objectType=article, longId=86080, objectId=30768608060, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30768608060, replyNumber=0, likeNumber=59, createdTime=2017-06-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30768608060, moduleTitle=重磅：CAR-T首次消灭实体瘤，意义非凡！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30768608060)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781131, encodeId=70221e811311a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=我国科学家利用CRISPR-Cas9技术在CAR-T细胞中实现多基因编辑, objectType=article, longId=83956, objectId=ea9b839562a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea9b839562a, replyNumber=0, likeNumber=66, createdTime=2017-10-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea9b839562a, moduleTitle=我国科学家利用CRISPR-Cas9技术在CAR-T细胞中实现多基因编辑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea9b839562a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781103, encodeId=ed2a1e8110394, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=免疫疗法CAR-T的“江湖人生”, objectType=article, longId=67149, objectId=cdd36e149b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdd36e149b7, replyNumber=0, likeNumber=79, createdTime=2016-08-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdd36e149b7, moduleTitle=免疫疗法CAR-T的“江湖人生”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdd36e149b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781130, encodeId=5dbb1e8113076, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败, objectType=article, longId=83111, objectId=9909831112d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9909831112d, replyNumber=0, likeNumber=55, createdTime=2017-07-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9909831112d, moduleTitle=两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9909831112d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781133, encodeId=0ac31e8113365, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, objectType=article, longId=85525, objectId=77d9855258f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77d9855258f, replyNumber=0, likeNumber=68, createdTime=2017-05-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77d9855258f, moduleTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77d9855258f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

艾森RTCA助力CAR-T疗法研究

2017-10-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：首次发现肿瘤复发后CAR-T细胞自发“复活”，并再起作用！

2017-10-16

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报

2017-12-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

博雅布局肿瘤免疫疗法上游，助力CAR-T治疗进入临床

2017-11-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

「创意支架」搭载CAR-T，联合免疫疗法助力消灭实体瘤！

2018-01-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

挑战实体瘤，CAR-T新锐的秘诀是？

2017-02-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤

2017-05-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

综述：CAR-T疗法、TCR-T疗法研发格局

2017-11-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

附属仁济医院李宗海团队CAR-T细胞治疗生物大楼落成启用

2018-04-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

人源CAR-T疗法挽救三位急淋白血病患者生命

2018-03-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

浙医一院CAR-T治疗恶性血液病进展振奋中美法专家

2017-05-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

美国FDA批准施维雅/辉瑞通用型CAR-T疗法进入临床试验

2017-09-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病

2017-03-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

艾辉胜教授：微移植和CAR-T联合治疗研究

2016-10-30

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Immunity：重大进展！利用新型CAR-T免疫疗法治疗实体瘤

2016-10-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

重磅：CAR-T首次消灭实体瘤，意义非凡！

2017-06-28

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

我国科学家利用CRISPR-Cas9技术在CAR-T细胞中实现多基因编辑

2017-10-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

免疫疗法CAR-T的“江湖人生”

2016-08-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败

2017-07-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！

2017-05-01

科室
- - 订阅+
  - 更多科室
工具
服务